PRECIGEN, INC. (PGEN) is a pharmaceutical preparations company incorporated in VA, listed on the Nasdaq. With a market capitalization of $1.3 billion, PRECIGEN, INC. is a small-cap company. The stock currently trades at $3.62, down 4.49% today, with a 52-week range of $1.11–$5.47.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2024 | $-0.47 | $-0.47 | -20.5% | |
| 2023 | $-0.39 | $-0.39 | -378.6% | |
| 2022 | $0.14 | $0.14 | +129.8% | |
| 2021 | $-0.47 | $-0.47 | — | |
| 2020 | — | — | — | |
| 2019 | — | — | — | |
| 2018 | — | — | — | |
| 2017 | — | — | — | |
| 2016 | $-0.28 | $-0.28 | +0.0% | |
| 2015 | $-0.28 | $-0.28 | -255.6% | |
| 2014 | $0.18 | $0.19 | +238.5% | |
| 2013 | $-0.13 | $-0.13 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2024-12-31 | 2025-03-19 | 0001356090-25-000007 | SEC ↗ |
| 2023-12-31 | 2024-03-19 | 0001356090-24-000007 | SEC ↗ |
| 2022-12-31 | 2023-03-06 | 0001356090-23-000004 | SEC ↗ |
| 2021-12-31 | 2022-03-01 | 0001356090-22-000002 | SEC ↗ |
| 2020-12-31 | 2021-03-01 | 0001356090-21-000003 | SEC ↗ |
| 2019-12-31 | 2020-03-02 | 0001628280-20-002699 | SEC ↗ |
| 2018-12-31 | 2019-03-01 | 0001356090-19-000004 | SEC ↗ |
| 2017-12-31 | 2018-03-01 | 0001356090-18-000002 | SEC ↗ |
| 2016-12-31 | 2017-03-01 | 0001356090-17-000003 | SEC ↗ |
| 2015-12-31 | 2016-02-29 | 0001356090-16-000092 | SEC ↗ |